Previous studies such as the Diabetic Retinopathy Clinical Research Network (DRCRN) Protocol S study [1] and the CLARITY study [2] revealed putative advantages of treating PDR with anti-VEGF injections versus pan-retinal laser photocoagulation. The gene discussed is VEGFA; the disease is diabetic retinopathy.